查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462721

高流量氧氣鼻管市場至2030年的預測：按組件、銷售管道、應用、最終用戶和地區的全球分析

High-flow Nasal Cannula Market Forecasts to 2030 - Global Analysis By Component, Sales Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球高流量氧氣鼻管市場規模為 77 億美元，預計在預測期內將以 14%的年複合成長率成長，到2030年達到 192.7 億美元。

高流量氧氣鼻管是一種呼吸治療裝置，可透過小鼻管以高流速輸送加熱、濕潤的氧氣。此療法用於治療急性呼吸衰竭患者，提供精確的氧合濃度，同時提供舒適感並減少呼吸功。加熱和加濕的氣體混合物提高了患者的耐受性和活動能力，同時高流量確保氣道開放，減少氣道阻力，並可能減少對有創機械通氣的需求。

根據世界衛生組織（WHO）估計，全球有 2.35 億人患有氣喘。

呼吸道疾病盛行率增加

慢性阻塞性肺病（COPD）、氣喘和急性呼吸窘迫症候群（ARDS）等呼吸道疾病在全球呈現上升趨勢。這些疾病通常需要有效的氧氣療法來緩解呼吸窘迫並改善患者的預後。高流量鼻插管對於呼吸系統疾病患者特別有益，因為與傳統氧氣療法方法相比，它們提供更高流量的氧氣。此外，它還提供恆定且可調節的氧氣供應，確保充足的氧合併減少患者呼吸系統的壓力。

高成本

HFNC 系統對於醫療保健提供者來說可能是一個經濟挑戰，因為與傳統的氧氣療法相比，它們相對昂貴。購買 HFNC 系統（包括流量產生器和加熱加濕器）所需的初始投資可能非常巨大。設備定期維護和校準的需要進一步增加了經濟負擔，限制了市場成長。

技術進步

HFNC 技術的不斷創新和改進提高了其性能、安全性和患者舒適度，推動了採用和利用率的提高。流量產生器、加熱加濕器和氧氣鼻管的設計創新提高 HFNC 治療的性能和舒適度。此外，製造商還推出了具有柔軟、靈活、符合解剖學輪廓的氧氣鼻管，可提高患者舒適度並減少皮膚刺激。插管設計的這些進步也有助於更佳輸送氧氣，並降低鼻部創傷的風險。

與替代呼吸輔助性治療的競爭

高流量氧氣鼻管（HFNC）市場面臨來自替代呼吸輔助性治療的競爭的限制。透過雙水平陽壓呼吸器（BiPAP）和持續性陽壓呼吸器（CPAP）等裝置提供的非侵入性通氣可提供不同程度的壓力支持，以幫助呼吸衰竭患者呼吸。此外，患有嚴重呼吸窘迫或急性呼吸衰竭的患者通常需要侵入性機械通氣，包括人工呼吸器支持。

COVID-19 的影響

COVID-19 大流行增加了對治療患有嚴重呼吸道症狀的患者的呼吸輔助設備的需求，推動了高流量氧氣鼻管（HFNC）市場，特別是與 COVID-19 相關的呼吸困難產生了巨大影響。此外，HFNC 能夠提供高流量氧氣療法，同時保持氣道最佳水合作用並減少有創通氣的需求，這使得 HFNC 對 COVID-19 患者特別是急性呼吸衰竭或急性呼吸窘迫症候群（ARDS）患者非常有用。

預計氧氣鼻管在預測期內將是最大的區隔

據估計，氧氣鼻管區隔所佔佔有率最大。氧氣鼻管由插入患者鼻孔的軟管和連接到調節氧氣流量的專用裝置的管子組成。高流量與加熱和加濕的氧氣相結合，可保持氣道的最佳水合作用，減少黏膜發炎並提高患者的舒適度。與傳統方法相比，高流量氧氣鼻管市場由於其在提供氧氣療法、改善患者治療效果和提高舒適度方面的有效性而經歷顯著成長。

預計急性呼吸衰竭在預測期內的年複合成長率最高

預計急性呼吸衰竭細分市場在預測期內將出現良好成長。透過以精確調節的流量提供溫暖、濕潤的氧氣，HFNC 可提高患者舒適度、減少氣道阻力並減少呼吸功。這些因素對於 ARF 的治療特別有益，因為患者經常會經歷呼吸困難和不適。此外，HFNC 治療可以避免在某些 ARF 病例中需要有創機械通氣，並降低與插管及其併發症相關的風險。

佔有率最大的地區

由於北美地區能夠有效地為有呼吸問題的患者提供高流量氧氣療法，因此在預測期內佔據了最大的市場佔有率。該地區擁有先進的醫療基礎設施和慢性呼吸道疾病的高盛行率，推動了對 HFNC 系統的需求。此外，該地區人口老化以及慢性阻塞性肺病（COPD）和睡眠呼吸中止症等疾病的高發生率也進一步支持了 HFNC 療法的採用。

年複合成長率最高的地區：

由於生活方式的改變，預計亞太地區在預測期內將出現盈利成長。污染程度的不斷上升、菸草消費和人口老化導致慢性阻塞性肺病（COPD）和呼吸道感染疾病等疾病的盛行率不斷上升，因此需要有效的治療方法，例如 HFNC 呼吸支持系統。此外，改善醫療基礎設施、擴大醫療服務範圍以及不斷上漲的醫療成本進一步刺激了亞太地區對先進呼吸護理設備的需求。

提供免費客製化：

訂閱此報告的客戶將收到以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球高流量氧氣鼻管市場：依組成部分

  • 加濕器
  • 氧氣鼻管
  • 單加熱管
  • 空氣/氧氣混合物
  • 其他組件

第6章 全球高流量氧氣鼻管市場：依銷售管道

  • 代理銷售
  • 直銷

第7章 全球高流量氧氣鼻管市場：依應用分類

  • 急性呼吸衰竭
  • 睡眠呼吸中止症
  • 一氧化碳毒性
  • 急性呼吸衰竭
  • 支氣管擴張
  • 慢性阻塞性肺病（COPD）
  • 其他用途

第8章 全球高流量氧氣鼻管市場：依最終用戶分類

  • Tomosynthesis
  • 門診治療中心
  • 醫院
  • 長期照護中心
  • 其他最終用戶

第9章 全球高流量氧氣鼻管市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Becton, Dickinson and Company
  • Fisher & Paykel Healthcare Corporation Ltd.
  • Flexicare Medical Ltd.
  • Great Group Medical Co., Ltd.
  • Hamilton Medical AG
  • MEK-ICS Co., Ltd.
  • Resmed Inc.
  • Salter Labs Inc.
  • Smiths Medical
  • Teijin Pharma Ltd.
  • Teleflex, Inc.
  • TNI Medical AG
  • Vapotherm, Inc.
Product Code: SMRC25772

According to Stratistics MRC, the Global High-flow Nasal Cannula Market is accounted for $7.7 billion in 2023 and is expected to reach $19.27 billion by 2030 growing at a CAGR of 14% during the forecast period. A high-flow nasal cannula is a respiratory therapy device that delivers heated and humidified oxygen at high flow rates through small nasal prongs. This therapy is used to treat patients with acute respiratory failure by providing precise oxygenation levels while offering comfort and reducing the work of breathing. The warmed and humidified gas mixture enhances patient tolerance and mobilization, while the high flow rates help to splint open airways, decrease airway resistance, and potentially reduce the need for invasive mechanical ventilation.

According to the World Health Organization It is estimated that 235 million people worldwide have asthma.

Market Dynamics:

Driver:

Rising prevalence of respiratory disorders

Respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and acute respiratory distress syndrome (ARDS) have been on the rise globally. These conditions often require effective oxygen therapy to alleviate respiratory distress and improve patient outcomes. High-flow nasal cannulas deliver a higher flow rate of oxygen compared to traditional oxygen therapy methods, making them particularly beneficial for patients with respiratory disorders. Moreover, they provide a constant and adjustable supply of oxygen, ensuring adequate oxygenation and reducing the workload on the patient's respiratory system.

Restraint:

High cost

HFNC systems can be relatively expensive compared to traditional oxygen therapy methods, which can pose financial challenges for healthcare providers. The initial investment required to purchase the HFNC system, including the flow generator and heated humidifier, can be substantial. The need for regular maintenance and calibration of the equipment further adds to the financial burden, which in turn limits market growth.

Opportunity:

Technological advancements

Ongoing innovations and improvements in HFNC technology have enhanced its performance, safety, and patient comfort, driving increased adoption and utilization. Innovations in flow generators, heated humidifiers, and nasal cannula design have enhanced the performance and comfort of HFNC therapy. Furthermore, manufacturers have introduced soft, flexible, and anatomically contoured nasal cannulas that enhance patient comfort and reduce skin irritation. These advancements in cannula design also contribute to better oxygen delivery and reduce the risk of nasal trauma.

Threat:

Competition from alternative respiratory support therapies

The high-flow nasal cannula (HFNC) market faces restraints due to competition from alternative respiratory support therapies. Non-invasive ventilation, delivered through devices such as bi-level positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP) provides varying levels of pressure support to assist breathing in patients with respiratory failure. Furthermore, invasive mechanical ventilation, involving end tracheal intubation and mechanical ventilator support, is often required for patients with severe respiratory distress or acute respiratory failure.

Covid-19 Impact

The COVID-19 pandemic has significantly impacted the high-flow nasal cannula (HFNC) market by increasing the demand for respiratory support devices to treat patients with severe respiratory symptoms, particularly those suffering from COVID-19-related respiratory distress. Moreover, due to its ability to deliver high-flow oxygen therapy while maintaining optimal airway hydration and reducing the need for invasive ventilation, HFNC has become a preferred option for treating COVID-19 patients, especially those experiencing acute respiratory failure or acute respiratory distress syndrome (ARDS).

The nasal cannula segment is expected to be the largest during the forecast period

The nasal cannula segment is estimated to hold the largest share. The nasal cannula consists of soft prongs that are inserted into the patient's nostrils, along with tubing connected to a specialized device that regulates the flow of oxygen. The high flow rate, combined with the heated and humidified oxygen, helps maintain optimal airway hydration, reduces mucosal irritation, and improves patient comfort. The high-flow nasal cannula market has experienced significant growth due to its effectiveness in delivering oxygen therapy, improving patient outcomes, and enhancing comfort compared to traditional methods.

The acute respiratory failure segment is expected to have the highest CAGR during the forecast period

The acute respiratory failure segment is anticipated to have lucrative growth during the forecast period. By delivering a precisely regulated flow of warm and humidified oxygen, HFNCs improve patient comfort, reduce airway resistance, and decrease the work of breathing. These factors are particularly beneficial in the management of ARF, where patients often experience respiratory distress and discomfort. Furthermore, HFNC therapy can prevent the need for invasive mechanical ventilation in some ARF cases, thereby reducing the risks associated with intubation and its complications.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to due to its efficacy in delivering high-flow oxygen therapy to patients with respiratory issues. This region boasts advanced healthcare infrastructure and a high prevalence of chronic respiratory diseases, driving the demand for HFNC systems. Additionally, the region's aging population and the incidence of conditions like chronic obstructive pulmonary disease (COPD) and sleep apnea further fuel the adoption of HFNC therapy.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to the lifestyle changes. Rising pollution levels, tobacco consumption, and an aging population contribute to the growing prevalence of conditions like chronic obstructive pulmonary disease (COPD) and respiratory infections, necessitating effective respiratory support systems such as HFNCs. Moreover, improving healthcare infrastructure, expanding access to healthcare services, and increasing healthcare expenditure further stimulate the demand for advanced respiratory care devices in APAC.

Key players in the market

Some of the key players in the High-flow Nasal Cannula Market include Becton, Dickinson and Company, Fisher & Paykel Healthcare Corporation Ltd., Flexicare Medical Ltd., Great Group Medical Co., Ltd., Hamilton Medical AG, MEK-ICS Co., Ltd., Resmed Inc., Salter Labs Inc., Smiths Medical, Teijin Pharma Ltd., Teleflex, Inc., TNI Medical AG and Vapotherm, Inc.

Key Developments:

In January 2024, BD (Becton, Dickinson and Company) and Techcyte announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and pre cancer using whole-slide imaging.

In November 2023, Teijin Limited announced that the company has entered into an exclusive license agreement with Ascendis Pharma A/S for the further development and commercialization of TransCon hGH, TransCon PTH, and TransCon CNP for endocrinology rare disease in Japan.

In March 2023, Becton Dickinson and the Agency for Science, Technology and Research have announced an extended research partnership that will focus on deep immune phenotyping of human tissues using spectral flow cytometry panels to bring forth discoveries that can be translated into positive healthcare outcomes.

Components Covered:

  • Air Humidifier
  • Nasal Cannula
  • Single Heated Tube
  • Air/Oxygen Blend
  • Other Components

Sales Channels Covered:

  • Distributor Sales
  • Direct Sales

Applications Covered:

  • Acute Respiratory Failure
  • Sleep Apnea
  • Carbon Monoxide Toxicity
  • Acute Respiratory Failure
  • Bronchiectasis
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Other Applications

End Users Covered:

  • Tomosynthesis
  • Ambulatory Care Centers
  • Hospitals
  • Long-term Care Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global High Flow Nasal Cannula Market, By Component

  • 5.1 Introduction
  • 5.2 Air Humidifier
  • 5.3 Nasal Cannula
  • 5.4 Single Heated Tube
  • 5.5 Air/Oxygen Blend
  • 5.6 Other Components

6 Global High Flow Nasal Cannula Market, By Sales Channel

  • 6.1 Introduction
  • 6.2 Distributor Sales
  • 6.3 Direct Sales

7 Global High Flow Nasal Cannula Market, By Application

  • 7.1 Introduction
  • 7.2 Acute Respiratory Failure
  • 7.3 Sleep Apnea
  • 7.4 Carbon Monoxide Toxicity
  • 7.5 Acute Respiratory Failure
  • 7.6 Bronchiectasis
  • 7.7 Chronic Obstructive Pulmonary Disease (COPD)
  • 7.8 Other Applications

8 Global High Flow Nasal Cannula Market, By End User

  • 8.1 Introduction
  • 8.2 Tomosynthesis
  • 8.3 Ambulatory Care Centers
  • 8.4 Hospitals
  • 8.5 Long-term Care Centers
  • 8.6 Other End Users

9 Global High Flow Nasal Cannula Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Becton, Dickinson and Company
  • 11.2 Fisher & Paykel Healthcare Corporation Ltd.
  • 11.3 Flexicare Medical Ltd.
  • 11.4 Great Group Medical Co., Ltd.
  • 11.5 Hamilton Medical AG
  • 11.6 MEK-ICS Co., Ltd.
  • 11.7 Resmed Inc.
  • 11.8 Salter Labs Inc.
  • 11.9 Smiths Medical
  • 11.10 Teijin Pharma Ltd.
  • 11.11 Teleflex, Inc.
  • 11.12 TNI Medical AG
  • 11.13 Vapotherm, Inc.

List of Tables

  • Table 1 Global High Flow Nasal Cannula Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 3 Global High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 4 Global High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 5 Global High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 6 Global High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 7 Global High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 8 Global High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 9 Global High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 10 Global High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 11 Global High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 13 Global High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 14 Global High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 15 Global High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 16 Global High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 17 Global High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 18 Global High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 19 Global High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 20 Global High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 21 Global High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 22 Global High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 23 Global High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 24 Global High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 27 North America High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 28 North America High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 29 North America High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 30 North America High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 31 North America High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 32 North America High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 33 North America High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 34 North America High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 35 North America High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 37 North America High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 38 North America High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 39 North America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 40 North America High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 41 North America High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 42 North America High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 43 North America High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 44 North America High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 45 North America High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 46 North America High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 47 North America High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 48 North America High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 51 Europe High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 52 Europe High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 53 Europe High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 54 Europe High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 55 Europe High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 56 Europe High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 57 Europe High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 58 Europe High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 59 Europe High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 60 Europe High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 61 Europe High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 62 Europe High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 63 Europe High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 64 Europe High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 65 Europe High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 66 Europe High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 67 Europe High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 68 Europe High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 69 Europe High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 70 Europe High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 71 Europe High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 72 Europe High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 75 Asia Pacific High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 76 Asia Pacific High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 77 Asia Pacific High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 78 Asia Pacific High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 79 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 80 Asia Pacific High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 81 Asia Pacific High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 82 Asia Pacific High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 83 Asia Pacific High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 84 Asia Pacific High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 85 Asia Pacific High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 86 Asia Pacific High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 87 Asia Pacific High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 88 Asia Pacific High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 89 Asia Pacific High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 90 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 91 Asia Pacific High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 92 Asia Pacific High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 93 Asia Pacific High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 94 Asia Pacific High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 95 Asia Pacific High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 96 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 99 South America High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 100 South America High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 101 South America High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 102 South America High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 103 South America High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 104 South America High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 105 South America High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 106 South America High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 107 South America High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 108 South America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 109 South America High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 110 South America High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 111 South America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 112 South America High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 113 South America High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 114 South America High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 115 South America High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 116 South America High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 117 South America High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 118 South America High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 119 South America High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 120 South America High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
  • Table 123 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
  • Table 124 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
  • Table 125 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
  • Table 126 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
  • Table 127 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 128 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 129 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
  • Table 130 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
  • Table 131 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
  • Table 132 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 133 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
  • Table 134 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
  • Table 135 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
  • Table 136 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
  • Table 137 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
  • Table 138 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 139 Middle East & Africa High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
  • Table 140 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
  • Table 141 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
  • Table 142 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 143 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
  • Table 144 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)